Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb’s 3Q16 Earnings: What’s Expected
Market Realist
Tue, 10/25/16 - 03:49 pm
Bristol-Myers Squibb
earnings
Merck, Bristol-Myers set to compete in bladder cancer
BioPharma Dive
Mon, 10/24/16 - 11:43 pm
Merck
Bristol-Myers Squibb
bladder
Keytruda
Opdivo
Earnings guide: A preview of 9 big pharmas in Q3
BioPharma Dive
Wed, 10/19/16 - 11:52 am
earnings
Roche
Merck
Eli Lilly
Novartis
GSK
Bristol-Myers Squibb
Sanofi
Pfizer
AstraZeneca
Pfizer and Bristol-Myers Squibb Could Face a Big Threat from Small Biotech Exelixis
Motley Fool
Mon, 10/17/16 - 11:49 am
Pfizer
Bristol-Myers Squibb
Exelixis
Cabometyx
kidney cancer
Sutent
Opdivo
Bristol-Myers receives positive CHMP opinion for Opdivo
Reuters
Fri, 10/14/16 - 11:50 am
Bristol-Myers Squibb
Opdivo
CHMP
relapsed or refractory Hodgkins lymphoma
How Large of a Role Does Opdivo Play in Bristol-Myers Squibb’s Success?
Market Realist
Wed, 10/12/16 - 11:26 am
Bristol-Myers Squibb
Opdivo
Merck outspends Bristol-Myers Squibb on journal ads for Keytruda
Medical Marketing and Media
Wed, 10/12/16 - 11:17 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
drug ads
How a Merck cancer breakthrough caused Bristol-Myers’ stock to plunge
Marketwatch
Tue, 10/11/16 - 09:53 am
Merck
Bristol-Myers Squibb
Opdivo
Keytruda
lung cancer
No silver lining in failed Bristol cancer drug trial
Yahoo/Reuters
Mon, 10/10/16 - 09:23 am
Bristol-Myers Squibb
Opdivo
lung cancer
Merck
Keytruda
Bristol-Myers Drops as Lung-Cancer Drug Disappoints Again
Yahoo/Bloomberg
Mon, 10/10/16 - 09:19 am
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
lung cancer
Pre-surgery use of Bristol's Opdivo 'safe and feasible' in lung cancer, study shows
Fierce Pharma
Sat, 10/8/16 - 03:57 pm
Bristol-Myers Squibb
Opdivo
lung cancer
New anti-PD1 drugs overpriced, ICER says
BioPharma Dive
Thu, 10/6/16 - 09:37 am
drug pricing
ICER
anti-PD-L1
Opdivo
Keytruda
Bristol-Myers Squibb
Merck
Bristol-Myers to test Opdivo with Nektar drug for several cancers
Yahoo/Reuters
Tue, 09/27/16 - 10:47 am
Bristol-Myers Squibb
Opdivo
Nektar
NKTR-214
PD-1 inhibitors
cancer
AVEO Collaborates With Bristol-Myers Squibb for RCC Drug
Investopedia
Fri, 09/23/16 - 09:43 am
Aveo Pharmaceuticals
Bristol-Myers Squibb
renal cell carcinoma
tivozanib
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
MRK: How Merck's Stock Price Rose 31.42% in 6 Months
Investopedia
Mon, 09/5/16 - 10:01 am
Merck
diabetes
immunotherapy
Opdivo
Bristol-Myers Squibb
Keytruda
Merck: Lung Cancer Lead Depends On “How Smart It Plays Its Hand”
Barron's
Wed, 08/31/16 - 08:54 pm
Merck
Bristol-Myers Squibb
lung cancer
Keytruda
Opdivo
California court hangs out a welcome sign: Drug makers can be sued here
patients
Tue, 08/30/16 - 11:38 am
lawsuits
California
Bristol-Myers Squibb
Plavix
Merck & Co., Inc. Gears Up For Extended Reach In Immunotherapies Race
Bidness, ETC
Fri, 08/26/16 - 09:58 am
Merck
Keytruda
Opdivo
Bristol-Myers Squibb
Lung cancer doctors eye Merck's Keytruda over Bristol's Opdivo
Yahoo/Reuters
Thu, 08/25/16 - 09:25 pm
lung cancer
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
…
next ›
last »